Articles in Scholarly Journals [Incomplete List]

1. Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
   Cancer Chemotherapy and Pharmacology, 2008
2. Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids
   Kidney International, vol. 72, no. 3, Article ID 5002364, 5 pages, 2007
3. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation
   Nephrology Dialysis Transplantation, vol. 22, no. 8, pp. 2412–2414, 2007
4. Peritoneal Protein Losses and Cytokine Generation in Automated Peritoneal Dialysis with Combined Amino Acids and Glucose Solutions
   Mediators of Inflammation, vol. 2007, Article ID 97272, 5 pages, 2007
5. Peritoneal Dialysis with Solutions Containing Amino Acids Plus Glucose Promotes Protein Synthesis during Oral Feeding
   Clinical Journal of the American Society of Nephrology, vol. 2, no. 1, pp. 74–80, 2006
6. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections
   Kidney International, vol. 67, no. 3, pp. 1084–1092, 2005
7. Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient
   Nephrology Dialysis Transplantation, vol. 17, no. 12, pp. 2252–2254, 2002
8. Peritonitis following endoscopic polypectomy in a peritoneal dialysis patient: The need for antibiotic prophylaxis
   Infection, vol. 22, no. 3, pp. 220–221, 1994
9. Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-a, PGE2 and nitrite, in vitro studies
   Immunology Letters, vol. 37, no. 1, pp. 27–33, 1993
10. Prostaglandin E2 inhibits the release of tumor necrosis factor-a, rather than interleukin 1ß, from human macrophages
    Immunology Letters, vol. 31, no. 1, pp. 85–90, 1992
11. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1ß
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 47, no. 1, pp. 23–28, 1992
12. Tumour necrosis factor in inflammation: relation to other mediators and to macrophage antitumour defence
    Pharmacological Research, vol. 24, no. 2, pp. 115–130, 1991
13. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis
    European Journal of Clinical Investigation, vol. 20, no. 4, pp. 453–457, 1990
14. Increasedin vitro release of interleukin-1 by LPS stimulated peritoneal macrophages obtained from patients on continuous ambulatory peritoneal dialysis (CAPD) during an infectious peritonitis
    Agents and Actions, vol. 29, no. 1-2, pp. 30–31, 1990
15. Infectious-inflammatory changes in cyclic AMP levels and in their regulation by prostaglandins in human peritoneal macrophages
    Prostaglandins, Leukotrienes and Medicine, vol. 18, no. 2, pp. 217–226, 1985
16. Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humans
    International Journal of Immunopharmacology, vol. 6, no. 6, pp. 547–555, 1984
17. Clinical application of a dosage regimen of amikacin, based upon lean body mass, age and serum creatinin concentrations
    Antonie van Leeuwenhoek, vol. 49, no. 2, pp. 203–204, 1983